Onera Health announced a strategic partnership with MedBridge Healthcare to deliver Onera’s self-applied, no-wire home polysomnography solution to people struggling with sleep disorders in the US.
The new partnership aims to broaden access to Onera’s medical-grade polysomnography-as-a-service solution, improving the patient experience and lowering the operational burden currently faced in many sleep clinics across the US, according to a press release by Onera Health.
“Onera Health and MedBridge Healthcare share the same values, so this partnership was an easy decision for us both. We’re working towards the same goal of improving the quality of life for people that suffer from sleep-related diseases through comprehensive testing,” says Ruben de Francisco, founder and CEO of Onera, in a press release. “I’m convinced our patient-centric type II polysomnography solution is the perfect addition to their already highly successful mail-to-home services.”
MedBridge operates a network of sleep disorder programs across the US, performing over 70,000 sleep procedures annually.
John Mathias, chief development officer of MedBridge, says in a press release, “As a leading sleep management service provider in the US, we are excited about the potential of Onera’s technology and its contribution to our end-to-end solution. We are pleased to extend our service through this partnership with at-home polysomnography systems that a patient can apply themselves within minutes. We firmly believe this will significantly improve the cost and access for testing, diagnosis, therapeutic coordination, and long-term care management of patients with sleep disorders.”
Onera and MedBridge plan to onboard the first customer for the home polysomnography service in the first half of the year.